TKD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 30.5 EUR Market Closed

Market Cap: €47.9B

T	Takeda Pharmaceutical Co Ltd XMUN:TKD	JP
	Takeda Pharmaceutical Co Ltd F:TKD	JP
B	BCPG PCL SET:BCPG	TH
E	Endo International PLC F:EO7	IE
	Lixil Corp OTC:JSGCF	JP
O	Ovid Therapeutics Inc F:1OT	US

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

11%

Operating Margin is Increasing

13% > 15%

Negative Net Margin

-3%

Low 3Y Average Net Margin

Declining Net Margin

7% > -3%

Exceptional Free Cash Flow Margin

14%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.